Follow Us

The AVCT Stock Rose 34%, Earnings Report Overwhelms The Bulls

Share on facebook
Share on twitter
Share on linkedin

Share

The AVCT Stock Rose 34%, Earnings Report Overwhelms The Bulls
Share on facebook
Share on twitter
Share on linkedin

Involved in the business of Affimer diagnostic products, Avacta Group (LON: AVCT) manufactures new Affimer medicines and licenses them to large pharma companies. It  operates through the Life Sciences and Animal Health segments

The Extraordinary Growth

In the Half-yearly report of June 2023, the Avacta group reported revenue of £11.1M, showing a remarkable growth of 115% Year on year (YoY), catering to many investors’ attention. Now, looking at a more comprehensive view, Last year’s revenue came with a growth of 228% while the gross profit margin was 43.8%. 

The company was making losses in its operations, which gives the answers to the revenue growth as the management is heavily reinvesting. Last year the management controlled its operational expenses by 12% compared to the previous year. 

Despite this cut, the net income for the last year was reported to be -£39.5M. Due to this negative net income, primary profitability ratios like earnings per share and return on equity are also negative and thus invalid to consider.

The increasing debt

One of the significant concerns to the investors is the company’s Debt-equity ratio, which, for the last year, was 3.4. That indicates it has 3.4 times more debt than its retained earnings and share capital. It means the company is heavily indebted.

Technical Analysis and Prediction of AVCT share price 

The AVCT Stock Rose 34%, Earnings Report Overwhelms The Bulls
Chart provided by TradingView (Daily time frame)

In April of last year, the AVCT share price reached a high of £140 before entering a slight bearish phase until the end of that year. The stock took a roller coaster ride between £95 and £137 during this time. 

However, in the new year of 2023, the bulls were finally able to break past the significant resistance levels. Consequently, the price reached the £185 mark in February of the same year. Since then, the AVCT share price went into a bearish phase, broken in September of this year after confirming the uptrend.

Correction is possible

This uptrend has broken some significant resistances at the press time. The current share price is trading at £154 as it rose after its half-yearly earnings report. The immediate resistance is at £1678, while the support for the bulls is at £140.

The RSI confirms that the stock has risen too fast to sustain, as it is at the overbought level of 77. That indicates a possible short-term correction. The AVCT share price prediction is bearish, as it is likely that the bears will reclaim the current resistance level.

Conclusion

Avacta Group (LON: AVCT) has posted positive earning reports over the past years. Recently, the half-yearly report was posted with huge revenue growth which made the stock surge up. The current price is near a resistance but the predfiction is bearish for the short term

Technical Levels

Support: £140, and £121

Resistance: £167, and £182

Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only. They do not establish financial, investment, or other advice. Investing in or trading in stocks comes with a risk of financial loss.

Leave a Reply

Your email address will not be published. Required fields are marked *

Download our App for getting faster updates at your fingertips.

en_badge_web_generic.b07819ff-300x116-1

We Recommend

Top Rated Cryptocurrency Exchange

Top Rated Crypto Broker
-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00